Dr. Jorge Victor Gavilondo
Immunotherapy Laboratory, Division of Pharmaceuticals, Center for Genetic Engineering and Biotechnology, La Habana, CUBA. EDUCATION: 1972: Graduate. Biology Faculty, Havana University. Specialist in Animal Physiology. 1975: M.Sc. degree at National Institute of Oncology and Radiobiology, Havana, Cuba, and the National Center for Scientific Research, Havana, Cuba. Thesis: "Cell kinetic studies in Hodgkin's disease". Specialist in Cell Biology and Radiobiology. 1976: IAEA Fellowship on Cellular and Molecular Radiobiology. Radiobiology Deptartment (tutor: Dr. Olga Djordjevic), Boris Kidrich Institute for Nuclear Sciences, Belgrade, Yugoslavia. 1980: IARC Fellowship. Viral Oncology Department (tutor: Prof. Luc Montagnier). Institute Pasteur, Paris, France. 1985: Ph.D. degree at the National Institute of Oncology and Radiobiology, Havana, and the National Center for Scientific Research, Havana, with thesis: "Experimental studies on neoplastic progression and the process of metastases". (Supervisors: Prof. Garth L. Nicolson, M.D. Anderson Hospital and Tumor Institute, Houston, USA; Dr. Agustin Lage, National Institute of Oncology and Radiobiology, Havana). PROFESSIONAL EXPERIENCE: 2000- : Project Leader. Immunotherapy Laboratory, Pharmaceuticals Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana. Fields of work: Cancer immunotherapy using recombinant antibodies. Development of recombinant antibody fragments in bacteria and yeast. Antibodies produced in transgenic plants. Cancer therapeutic vaccines. 1991-99: Head, Division of Immunotechnology and Diagnostics, same institution. Fields of work: Development of therapeutic mouse, human and recombinant MAbs. Research, development and production of diagnostic kits and reagents based on MAbs, recombinant proteins, and synthetic peptides. 1988-91: Head, Division of Hybridomas and Animal Models, same institution. Fields of work: Development of mouse, human and recombinant MAbs. Development and production of diagnostic and lab Mabs. Transgenesis in several species. Toxicology of natural and recombinant products. 1986-88: Head, Hybridoma Laboratory, Vaccine Division, same institution. Fields of work: Development of murine and human hybridomas, and production of MAbs against infectious agents and biomolecules. 1980-86: Head, Department of Tumor Biology, Institute of Oncology and Radiobiology of Havana. Fields of work: Neoplastic progression and experimental metastases. Murine hybridomas and production of MAbs against tumor-associated antigens. Manipulation of murine and human transformed and tumor cells in vitro and in vivo.
1977-79: Head, Department of Biochemistry, same institution. Fields of work: Experimental chemotherapy, new anti-tumor drugs from natural sources. Manipulation of murine and human transformed and tumor cells in vitro and in vivo. 1972-75: Head, Radiobiology Laboratory, same institution. Fields of work: Tumor cell kinetics studies in Hodgkin’s Disease. Autorradiography in tissues and cells. SOCIETIES: 1. Full Academician, Cuban Academy of Sciences (2006-2012; 2012-date). 2. Member of the Council, International Union of Immunological Societies (IUIS) (2003-2007). 3. Vice President, Cuban Immunology Society (2004-2010). 4. Member of the Executive, Latin-American Association of Immunological Societies, ALAI (2003-2005). 5. President, Latin-American Association of Immunological Societies, ALAI (1999-2002). 6. Member of the Latin American Council for Experimental Biology (CLABE) (1996-2001). 7. Institute of Sustainable Sciences, Board (2000-2005). 8. Cuban Immunology Society, Board (1996-2004). 9. Iberolatinoamerican Society for Biotechnology Applied to Health. Member. 10. Iberolatinoamerican Society for Genetic Engineering and Biotechnology. Board.
EXPERT AND CONSULTANT ASSIGNMENTS: 2008-date: Consultant, Panorama Research Inc., Sunnyvale, CA, USA. 2008.- Invited Expert. Director’s Advisor Committee for Research in Health (ACRH). Pan American Health Organization, Rio de Janeiro, Brasil